Management of Sub-Acute Exacerbation of Bronchial Asthma with Blatta orientalis: A Case Report

Psoriasis is a chronic skin disease with manifestations in skin, nails and joints. The disease usually runs a long course of remission and relapses, and is usually worse in winters. Psoriasis Area and Severity Index (PASI) score above 15 is considered to be an independent criterion for classifying a case as severe psoriasis. The conventional systemic therapy controls the symptoms but is costly and has known adverse effects. Individualised homoeopathic treatment has a potential role in providing safe and cost-effective treatment in psoriasis. In this article, three cases of severe psoriasis vulgaris treated with Homoeopathy at Bakson Homoeopathic Medical College and hospital are presented. Two cases were under treatment for a period of 20 months and one case received treatment for 24 months. Significant reduction (60–100%) in PASI score was observed with individualised homoeopathic treatment.

show abstract

“…Various published case reports on the treatment of psoriasis by homoeopathy have demonstrated encouraging results. 15 16 17…”

Section: Discussionmentioning

confidence: 99%

Evidence-Based Treatment of Severe Psoriasis by Individualised Homoeopathy: Case Reports

Gupta

Nair²,

Rana

2022

Homœopathic Links

View full text Add to dashboard Cite

show abstract

“…The differential diagnosis of PP includes atopic dermatitis (history of hay fever and asthma), contact dermatitis (no silvery scale), lichen planus (involves the wrist and ankles with less scale), seborrheic dermatitis (greasy scale), onychomycosis, tinea corporis (thinner scale with potassium hydroxide preparation), pityriasis rosea, osteomyelitis and mycosis fungoides (less distinct lesion borders). [9][10][11][12][13][14] Homoeopathic literature review revealed a case study done on PP and homoeopathy on a 66-year-old male patient through individualised homoeopathic therapy Sulphur 1M along with the Sulphur-based cosmetic cream. The results were significant within the 4 months of treatment.…”

Section: Introductionmentioning

confidence: 99%

Plaque Psoriasis Successfully Treated with an Individualised Homoeopathic Medicine Lycopodium: A Case Report

Kanwar¹,

Ram

Kumar

et al. 2020

Homœopathic Links

Self Cite

View full text Add to dashboard Cite

Introduction Psoriasis is an immune-mediated disease affecting the skin and joints with a prevalence of 0.44 to 2.8% in India. This manifests most often as plaque psoriasis (PP); it is a chronic, relapsing, inflammatory skin disorder with a strong genetic basis. PP is rarely life threatening but it is often intractable to treatment. Here, a 31-year-old male diagnosed with PP presented with a history of multiple reddish moist lesions with thickness and scaling of skin from right forearm, chest, abdomen and back for 3 years. Patient was taking allopathic medications for the same but there was only temporary relief of the complaints. So, patient approached for homeopathic intervention for permanent cure. On the basis of the totality of symptoms and analysis by repertorisation, homoeopathic medicine Lycopodium was prescribed and repetition was done according to the response of medicine and as per the condition of patient, following the principles of homoeopathy. It showed improvement in all complaints, but there was relapse of eruptions after sometime which called for increase in the potency of the Lycopodium (200C & 1M) as per homoeopathic principles. The assessment of patient was done on the basis of Psoriasis Area and Severity Index (PASI) score and photographic evidence. The PASI score of the patient at baseline was 23.4 and it was reduced to 1 after the continuous follow-up of patient for 1 year. Photographs during follow-up visits have provided a documentary evidence about the effectiveness of homoeopathic medicine Lycopodium in plaque psoriasis. Thus, it can be concluded that homoeopathy plays an effective role in managing the cases of PP symptomatically along with complete recovery of the patient.

show abstract

“…9 A case report of 32-year-old female with sub-acute exacerbation of bronchial asthma treated with Blatta orientalis 30C showed significant improvement in Elizabeth Junipers ACQ Score and spirometry along with reduction in number of attacks after 6 months of treatment. 10 An experimental animal model study was conducted to evaluate the antiasthmatic and anti-anaphylactic activities of Blatta orientalis mother tincture (MT). This study showed significant protection against acetylcholine and histamine aerosol-induced bronchospasm in treated with Blatta Orientalis guinea pigs.…”

Section: Introductionmentioning

confidence: 99%

Effects of Blatta orientalis on Treatment of Bronchial Asthma: A Prospective, Non-Randomised, Open-Label, Observational Study

Ram

Choudhary²,

Dewan

et al. 2020

Homœopathic Links

Self Cite

View full text Add to dashboard Cite

Background Bronchial asthma is a globally significant non-communicable disease with major public health consequences for both children and adults, including high morbidity, and relatively low mortality compared with other chronic diseases. It is a chronic disorder that enables the patient to take lifelong medications including bronchodilators. Aim: This study was undertaken to ascertain the effects of Blatta orientalis in potency on the treatment of bronchial asthma assessed by spirometry and Asthma Control Questionnaire (ACQ) Score. Method A prospective, non-randomised, open-label, observational study was conducted at Dr. MPK Homoeopathic Medical College, Hospital & Research Centre, Jaipur, Rajasthan, from 2015 to 2016. Patients between 5 and 80 years of age suffering from dyspnoea, cough with expectoration and wheezing were screened. The convenience sampling technique was used to enrol 120 patients, after fulfilling the inclusion and exclusion criteria of the study. The patients of Bronchial asthma were treated with Blatta orientalis in potency for 6 months. Patients were diagnosed and assessed on the basis of the ACQ Score by Elizabeth Junipers and spirometry findings. Blatta orientalis was prescribed to all patients in increasing potency from 30C. The paired t-test is applied to calculate the statistical significance of the study. Result Out of 120 patients, 100 had completed the study with follow-up of 6 months. A significant difference was found in pre- and post-treatment spirometry—that is, forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio—from baseline to 6 months (mean ± standard deviation [SD]: –10.27 ± 4.95; 95% confidence interval [CI]: –11.25 to –9.28; p = 0.00001). Also, significant difference was seen in the ACQ Score from baseline to 6 months (mean ± SD: 19.44 ± 8.69; 95% CI: 17.71–21.16; p = 0.00001). Conclusion The study findings are encouraging enough to prescribe Blatta orientalis in potency in cases of bronchial asthma. Further systematic replication is required to be conducted as randomised controlled trials with long-term follow-ups for definite conclusions.

show abstract

Management of Sub-Acute Exacerbation of Bronchial Asthma with Blatta orientalis: A Case Report

Cited by 3 publications

References 7 publications

Evidence-Based Treatment of Severe Psoriasis by Individualised Homoeopathy: Case Reports

Evidence-Based Treatment of Severe Psoriasis by Individualised Homoeopathy: Case Reports

Plaque Psoriasis Successfully Treated with an Individualised Homoeopathic Medicine Lycopodium: A Case Report

Effects of Blatta orientalis on Treatment of Bronchial Asthma: A Prospective, Non-Randomised, Open-Label, Observational Study

Contact Info

Product

Resources

About